Anti-adhesive Effect and Safety of "Thermo-sensitive Adhesion Barrier (MEDICLORE)"
NCT03293186 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2021-03-17
Summary
One of most important complication of thyroid surgery is adhesion. There are many anti-adhesive materials, but none of them showed significant outcomes. The investigators planned double blind prospective study of "Thermo-sensitive Adhesion Barrier (MEDICLORE)" to reveal anti-adhesive effect of MEDICLORE. The investigators will recruit total 90 patients (control group 45, experimental group 45) and compare postoperative outcomes about adhesion.
Conditions
- Adhesion
- Thyroidectomy
Interventions
- COMBINATION_PRODUCT
-
MEDICLORE
use MEDICLORE at the end of surgery as antiadhesive product
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2020-12-27
- Completion
- 2020-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical Product
NCT04845867 ·Status: RECRUITING
-
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
NCT00295763 ·Status: COMPLETED ·Phase: PHASE3
-
The Improvement of Intraoperative Neuromonitoring of Recurrent Laryngeal Nerve
NCT03911232 ·Status: COMPLETED ·Phase: NA
-
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
NCT04354324 ·Status: RECRUITING ·Phase: NA
-
Three-Year Follow-up of Radioiodine Therapy for Goitre
NCT00509483 ·Status: COMPLETED ·Phase: NA
-
Pilot Study for Thyroid Surgery by Preoperative Video Support and Personalized and Secure Web Platform
NCT04571736 ·Status: RECRUITING ·Phase: NA
-
Block-replacement Therapy During Radioiodine Therapy
NCT00150124 ·Status: COMPLETED ·Phase: PHASE4
-
Antithyroid Drugs During Radioiodine Therapy
NCT00150137 ·Status: COMPLETED ·Phase: PHASE4
-
Adequate Dosage of Sugammadex on Thyroid Surgery
NCT03689413 ·Status: COMPLETED ·Phase: NA
-
Influence of Thyroid Hormones on the Woundhealing Process
NCT00929318 ·Status: UNKNOWN ·Phase: NA
-
Clinical and Surgical Outcomes of Total Thyroidectomy in Basedow's Disease: the Effect of Lugol Solution
NCT05784792 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
NCT02706743 ·Status: UNKNOWN
-
Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism
NCT02317926 ·Status: UNKNOWN ·Phase: NA
-
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
NCT00435851 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Usefulness of Fluorescence in Thiroid Surgery
NCT06011369 ·Status: UNKNOWN ·Phase: NA
-
The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients
NCT03024151 ·Status: COMPLETED ·Phase: NA
-
Improved Preoperative Selection of Cold Thyroid Nodules
NCT00297297 ·Status: UNKNOWN
-
The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery
NCT02039427 ·Status: COMPLETED ·Phase: NA
-
2-day Prophylactic Antibiotic is Effective in Transoral Endoscopic Thyroidectomy
NCT04268407 ·Status: COMPLETED ·Phase: NA
-
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171 ·Status: UNKNOWN ·Phase: PHASE4
-
Thyroid Dysfunction in Head and Neck Surgery Patients
NCT00592514 ·Status: COMPLETED
-
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
NCT05142904 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
NCT00094055 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Lugol's Solution in the Patients With Graves' Disease
NCT00432146 ·Status: COMPLETED
-
TOETVA Feasibility and Complications - Single Center First Experience
NCT05396703 ·Status: COMPLETED